PeptidePedia The community reference

Special:RecentChanges

Change log·3,390 revisions·page 4 of 34

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 3,390 changes are logged in total.

3,390Logged changes
303Bot edits
37Page creations
253Active editors

21 May 2026

  1. (diff | hist) 02:01 Reconstitution calculator 8,662 ±0 DPP4_Dagmar (talk | contribs) attribute claim in-text [rollback]

20 May 2026

  1. (diff | hist) 19:36 Shanghai Wibson Biotechnology 11,996 ±0 TirzTaxonomist (talk | contribs) correct transposed digits [rollback]

19 May 2026

  1. (diff | hist) 20:37 Syringe dead space 20,968 ±0 GramsNotUnitsGil (talk | contribs) add citation [rollback]
  2. (diff | hist) 18:56 Flourishglobal Peptide Biotech 12,100 ±0 ForgeryFinder (talk | contribs) add figure [rollback]
  3. (diff | hist) 17:21 Glucose-dependent insulinotropic polypeptide 8,265 ±0 CouplingCillian (talk | contribs) merge two short sections [rollback]
  4. (diff | hist) 17:03 Talk:Cold chain 1,296 +269 ColdChainCleo (talk | contribs) /* Domestic refrigerator claim: which studies? */ reply
  5. (diff | hist) 14:22 Talk:Cold chain 1,085 +344 LabRangeLindy (talk | contribs) /* Domestic refrigerator claim: which studies? */ new section
  6. (diff | hist) m 07:55 Qingdao Sigma Chemical 12,284 ±0 MicrodoseMagnus (talk | contribs) tag [citation needed] [rollback]
  7. (diff | hist) 03:21 GL Biochem (Shanghai) 13,879 ±0 ForgeryFinder (talk | contribs) consistent en dashes in ranges [rollback]

18 May 2026

  1. (diff | hist) m b 18:24 Sangon Biotech 12,025 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]

16 May 2026

  1. (diff | hist) 22:05 Tianjin Finder Chemical 11,889 ±0 NotabilityNoa (talk | contribs) add short description [rollback]
  2. (diff | hist) m 14:52 Nantong Guangyuan Chemical 12,306 ±0 BatchNumberBede (talk | contribs) attribute range as a review estimate per talk [rollback]
  3. (diff | hist) m 13:39 Glucagon-like peptide-1 12,294 ±0 LCellLeif (talk | contribs) de-orphan [rollback]
  4. (diff | hist) m 11:26 Shanghai ERP Biotechnology 11,702 ±0 GHK_Gwendolen (talk | contribs) ce, tighten prose [rollback]
  5. (diff | hist) 09:18 Trial data comparison 7,303 ±0 DrTitration (talk | contribs) consistent en dashes in ranges [rollback]
  6. (diff | hist) 04:18 Xi'an Mokemei Biotechnology 12,475 ±0 RetinopathyRex (talk | contribs) rm maintenance tag, addressed [rollback]

15 May 2026

  1. (diff | hist) 20:03 Hubei Jianxiang Bioscience 12,122 ±0 CheckSumChase (talk | contribs) correct percentage: source reports placebo-adjusted [rollback]
  2. (diff | hist) 11:11 Chinese Peptide Company 12,627 ±0 SyringeSybille (talk | contribs) British spelling per PP:MOS [rollback]
  3. (diff | hist) m 07:53 Shanghai Sigma-Audley New Material Technology 12,666 ±0 SigFigSindri (talk | contribs) ce per MOS [rollback]
  4. (diff | hist) m b 03:56 Insulin syringe unit conversion 6,290 ±0 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  5. (diff | hist) 01:53 Qingdao Saber Technology Pharmaceutical 11,956 ±0 Ref_Desk_Ron (talk | contribs) lead should summarise the body, not add to it [rollback]

14 May 2026

  1. (diff | hist) 13:39 Multi-dose vial 24,628 ±0 RedirectRini (talk | contribs) convert list to prose [rollback]
  2. (diff | hist) 09:38 Talk:Sangon Biotech 959 +235 PrimarySrcPatia (talk | contribs) /* Comparing documentation within one organisation */ reply
  3. (diff | hist) 08:26 Talk:Syringe dead space 1,444 +127 CrossRefCleve (talk | contribs) /* Should this article carry the vial-yield table, or should the calculator? */ reply
  4. (diff | hist) m 07:05 Enteroendocrine L cell 5,083 ±0 ReceptorRhoda (talk | contribs) add PMID [rollback]
  5. (diff | hist) 06:50 ChinaPeptides 12,304 ±0 SerialCommaSeb (talk | contribs) rv addition of price information per PP:VN [rollback]
  6. (diff | hist) 05:59 Wuhan Wansheng Biotechnology 12,729 ±0 FootnoteFyfe (talk | contribs) ce per MOS [rollback]
  7. (diff | hist) 02:30 Syringe dead space 20,968 ±0 DrTitration (talk | contribs) split overlong sentence [rollback]

13 May 2026

  1. (diff | hist) m 20:44 Temperature excursion 24,964 ±0 DisclosureDido (talk | contribs) fix significant figures — source gives fewer [rollback]
  2. (diff | hist) 15:22 Talk:Sangon Biotech 748 +165 TallySheetTad (talk | contribs) /* Comparing documentation within one organisation */ reply
  3. (diff | hist) 13:45 Zhuhai Kerui Biotechnology 12,118 ±0 COA_Colwyn (talk | contribs) convert list to prose [rollback]
  4. (diff | hist) m b 13:27 Guangzhou JEEP Biotechnology 12,891 ±0 CiteBot (talk | contribs) bot: update parent category chain [rollback]
  5. (diff | hist) 12:47 Talk:Sangon Biotech 537 +344 COA_Colwyn (talk | contribs) /* Comparing documentation within one organisation */ new section
  6. (diff | hist) 09:01 Talk:Syringe dead space 1,233 +198 UnitsUrsula (talk | contribs) /* Should this article carry the vial-yield table, or should the calculator? */ reply
  7. (diff | hist) 00:50 Beyond-use date 23,171 ±0 IsocraticIla (talk | contribs) add category [rollback]

12 May 2026

  1. (diff | hist) 23:32 Vial 26,012 ±0 SurpassSunniva (talk | contribs) add see also [rollback]
  2. (diff | hist) 20:01 Hunan Aslsen Technology 12,103 ±0 DMF_Dermot (talk | contribs) reorder sections to follow the class template [rollback]
  3. (diff | hist) 13:39 Talk:Syringe dead space 1,022 +246 PlainNumbersPip (talk | contribs) /* Should this article carry the vial-yield table, or should the calculator? */ reply
  4. (diff | hist) 11:14 Talk:Syringe dead space 811 +160 CrossRefCleve (talk | contribs) /* Should this article carry the vial-yield table, or should the calculator? */ new section

11 May 2026

  1. (diff | hist) 11:33 Talk:Temperature excursion 1,581 +211 ManualOfStyleMo (talk | contribs) /* Assessment sequence reads as a procedure */ reply
  2. (diff | hist) m 09:25 Karl Fischer titration 9,318 ±0 TFA_Counterion (talk | contribs) state the assay for the reference interval [rollback]
  3. (diff | hist) 09:04 Bachem Holding (Suzhou) 12,136 ±0 ManualOfStyleMo (talk | contribs) fix unit [rollback]

10 May 2026

  1. (diff | hist) 23:33 WuXi TIDES 13,269 ±0 ReportReaderRilla (talk | contribs) split section [rollback]
  2. (diff | hist) 18:36 Cold chain 27,220 ±0 SPPS_Sorrel (talk | contribs) fix hyphenation per PP:MOS [rollback]
  3. (diff | hist) 08:52 Flourishglobal Peptide Biotech 12,100 ±0 DefinedTermDov (talk | contribs) expand §Distribution and dispatch [rollback]
  4. (diff | hist) 05:16 Shanghai Wibson Biotechnology 11,996 ±0 Chromatokid (talk | contribs) tag [citation needed] [rollback]

9 May 2026

  1. (diff | hist) 09:07 Talk:Temperature excursion 1,370 +151 ToneTilda (talk | contribs) /* Assessment sequence reads as a procedure */ reply

8 May 2026

  1. (diff | hist) 22:39 Shanghai ERP Biotechnology 11,702 ±0 TrialsTabitha (talk | contribs) British spelling per PP:MOS [rollback]
  2. (diff | hist) m b 21:00 Peptide stability table 6,886 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  3. (diff | hist) 14:43 Sangon Biotech 12,025 ±0 Chromatokid (talk | contribs) replace primary source with the review [rollback]
  4. (diff | hist) 14:22 Talk:Temperature excursion 1,159 +323 Hedgerow_Hal (talk | contribs) /* Assessment sequence reads as a procedure */ reply
  5. (diff | hist) m b 11:45 Lyophilisation 28,679 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  6. (diff | hist) 10:44 Talk:Temperature excursion 948 +287 ToneTilda (talk | contribs) /* Assessment sequence reads as a procedure */ new section
  7. (diff | hist) 08:41 Talk:Trial data comparison 1,033 +120 ForestPlotFinn (talk | contribs) /* Cross-trial tabulation and the estimand problem */ reply

7 May 2026

  1. (diff | hist) 22:42 Tianjin Finder Chemical 11,889 ±0 BalanceBirdie (talk | contribs) undo good-faith edit: the source does not say this [rollback]
  2. (diff | hist) 09:15 Talk:Trial data comparison 822 +256 TrialsTabitha (talk | contribs) /* Cross-trial tabulation and the estimand problem */ reply
  3. (diff | hist) 07:18 Reconstitution calculator 8,662 ±0 FiveOhThreeB (talk | contribs) lead should summarise the body, not add to it [rollback]
  4. (diff | hist) m 06:28 GL Biochem (Shanghai) 13,879 ±0 PreregPriya (talk | contribs) add comparator rate [rollback]
  5. (diff | hist) 04:40 Syringe dead space 20,968 ±0 MicrodoseMagnus (talk | contribs) consistent en dashes in ranges [rollback]

6 May 2026

  1. (diff | hist) 13:48 Talk:Trial data comparison 611 +105 ITT_Imelda (talk | contribs) /* Cross-trial tabulation and the estimand problem */ reply
  2. (diff | hist) 10:30 Incretin effect 7,358 ±0 ToneTilda (talk | contribs) expand §Loss of the incretin effect in disease [rollback]
  3. (diff | hist) 10:22 Talk:Trial data comparison 400 +461 ForestPlotFinn (talk | contribs) /* Cross-trial tabulation and the estimand problem */ new section
  4. (diff | hist) m b 08:30 Trial data comparison 7,303 ±0 CategoryBot (talk | contribs) bot: add stub category [rollback]
  5. (diff | hist) m b 06:22 Xi'an Mokemei Biotechnology 12,475 ±0 ArchiveBot (talk | contribs) bot: expand DOI to full citation [rollback]
  6. (diff | hist) m 05:16 Qingdao Saber Technology Pharmaceutical 11,956 ±0 PrimarySrcPatia (talk | contribs) fix arithmetic in worked example [rollback]

5 May 2026

  1. (diff | hist) 21:34 Nantong Guangyuan Chemical 12,306 ±0 SecondarySrc_Seb (talk | contribs) add {{refimprove}} [rollback]
  2. (diff | hist) m b 10:54 Hubei Jianxiang Bioscience 12,122 ±0 ArchiveBot (talk | contribs) bot: expand DOI to full citation [rollback]
  3. (diff | hist) 09:37 Temperature excursion 24,964 ±0 CustomsClarke (talk | contribs) add {{refimprove}} [rollback]
  4. (diff | hist) m 02:55 ChinaPeptides 12,304 ±0 DeadSpaceDot (talk | contribs) ce per MOS [rollback]

4 May 2026

  1. (diff | hist) m 14:59 Glucose-dependent insulinotropic polypeptide 8,265 ±0 LCellLeif (talk | contribs) add category [rollback]

3 May 2026

  1. (diff | hist) 23:35 Glucagon-like peptide-1 12,294 ±0 IncretinIvo (talk | contribs) fix significant figures — source gives fewer [rollback]
  2. (diff | hist) 18:50 Chinese Peptide Company 12,627 ±0 CheckSumChase (talk | contribs) attribute claim in-text [rollback]
  3. (diff | hist) 14:29 Multi-dose vial 24,628 ±0 SyringeSybille (talk | contribs) expand §The period after initial puncture [rollback]
  4. (diff | hist) m 01:11 Shanghai Sigma-Audley New Material Technology 12,666 ±0 ChainCustodyChad (talk | contribs) correct percentage: source reports placebo-adjusted [rollback]
  5. (diff | hist) m 00:40 Vial 26,012 ±0 StopperingSteff (talk | contribs) update infobox [rollback]

2 May 2026

  1. (diff | hist) 14:03 Talk:Incretin effect 822 +275 PlainNumbersPip (talk | contribs) /* Percentage calculation — should the formula be explained further? */ reply
  2. (diff | hist) 11:42 Talk:Incretin effect 611 +239 Peptide_Pete (talk | contribs) /* Percentage calculation — should the formula be explained further? */ reply
  3. (diff | hist) m 10:30 Syringe dead space 20,968 ±0 Compounding_Cate (talk | contribs) add citation for the incidence figure [rollback]
  4. (diff | hist) 09:15 Talk:Incretin effect 400 +213 PlainNumbersPip (talk | contribs) /* Percentage calculation — should the formula be explained further? */ new section
  5. (diff | hist) 08:31 Insulin syringe unit conversion 6,290 ±0 OralSemaOswin (talk | contribs) fix unit [rollback]
  6. (diff | hist) 03:07 Shanghai ERP Biotechnology 11,702 ±0 Chromatokid (talk | contribs) promote subsection to section [rollback]

1 May 2026

  1. (diff | hist) 20:11 Zhuhai Kerui Biotechnology 12,118 ±0 Hedgerow_Hal (talk | contribs) convert prose to table for comparability [rollback]
  2. (diff | hist) 14:45 Bachem Holding (Suzhou) 12,136 ±0 SurvodutideSaff (talk | contribs) link to the policy rather than restating it [rollback]
  3. (diff | hist) 12:27 Qingdao Sigma Chemical 12,284 ±0 PurityClaimPia (talk | contribs) add table [rollback]
  4. (diff | hist) 10:07 Beyond-use date 23,171 ±0 NurseNoteNessa (talk | contribs) correct molar mass [rollback]
  5. (diff | hist) 06:40 Cold chain 27,220 ±0 DeadSpaceDot (talk | contribs) add confidence interval [rollback]
  6. (diff | hist) 05:41 Guangzhou JEEP Biotechnology 12,891 ±0 ForgeryFinder (talk | contribs) consistent en dashes in ranges [rollback]
  7. (diff | hist) 04:39 Wuhan Wansheng Biotechnology 12,729 ±0 ForestPlotFinn (talk | contribs) add category [rollback]

30 April 2026

  1. (diff | hist) 10:26 Talk:Vial 1,581 +65 Ref_Desk_Ron (talk | contribs) /* Should the excess-volume table be here or at Underfilling? */ reply

29 April 2026

  1. (diff | hist) 08:14 Hunan Aslsen Technology 12,103 ±0 BlankVialBo (talk | contribs) expand §Independent testing record [rollback]
  2. (diff | hist) 07:34 Peptide stability table 6,886 ±0 SchemaSorcha (talk | contribs) remove weasel wording [rollback]
  3. (diff | hist) 04:11 WuXi TIDES 13,269 ±0 SurrogateSunday (talk | contribs) lead should summarise the body, not add to it [rollback]
  4. (diff | hist) 02:20 Shanghai Wibson Biotechnology 11,996 ±0 LotTraceLuka (talk | contribs) rv restoration of unsourced claim [rollback]

28 April 2026

  1. (diff | hist) m b 17:36 Karl Fischer titration 9,318 ±0 CategoryBot (talk | contribs) bot: update parent category chain [rollback]
  2. (diff | hist) 09:47 Talk:Vial 1,370 +132 SeeAlsoSelma (talk | contribs) /* Should the excess-volume table be here or at Underfilling? */ reply

27 April 2026

  1. (diff | hist) m 21:36 Lyophilisation 28,679 ±0 FmocFrancis (talk | contribs) move unsourced paragraph to talk [rollback]
  2. (diff | hist) 19:49 Flourishglobal Peptide Biotech 12,100 ±0 SatietySunniva (talk | contribs) label community tally as self-reported [rollback]
  3. (diff | hist) m 18:46 Qingdao Saber Technology Pharmaceutical 11,956 ±0 CouplingCillian (talk | contribs) add PMID [rollback]
  4. (diff | hist) 16:02 Talk:Vial 1,159 +407 UnderfillUna (talk | contribs) /* Should the excess-volume table be here or at Underfilling? */ reply
  5. (diff | hist) 13:19 Talk:Vial 948 +226 CrossRefCleve (talk | contribs) /* Should the excess-volume table be here or at Underfilling? */ new section